PortfoliosLab logo

BioLineRx Ltd. (BLRX)

Equity · Currency in USD · Last updated Aug 6, 2022

Company Info

ISINUS09071M2052
CUSIP09071M205
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$1.74
Year Range$1.06 - $3.06
EMA (50)$1.39
EMA (200)$1.84
Average Volume$107.98K
Market Capitalization$75.66M

BLRXShare Price Chart


Chart placeholderClick Calculate to get results

BLRXPerformance

The chart shows the growth of $10,000 invested in BioLineRx Ltd. in Jul 2011 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $208 for a total return of roughly -97.92%. All prices are adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%MarchAprilMayJuneJulyAugust
-3.26%
-9.64%
BLRX (BioLineRx Ltd.)
Benchmark (^GSPC)

BLRXReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M33.85%8.19%
6M0.58%-7.42%
YTD-14.71%-13.03%
1Y-42.57%-5.85%
5Y-36.14%10.86%
10Y-27.32%11.49%

BLRXMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-10.78%-16.48%12.50%-28.65%27.87%-17.95%3.13%31.82%
202110.71%10.75%-9.71%12.54%-8.92%-1.75%14.95%-11.15%-4.18%3.27%-7.39%-22.43%
20204.89%-20.34%-29.26%26.32%15.48%-11.86%32.75%-19.82%-9.89%20.73%15.66%10.04%
201950.93%-37.88%4.88%-9.58%-8.33%2.41%-27.49%-28.21%-7.37%-1.14%0.38%-14.12%
2018-1.83%-6.56%-12.98%-8.00%15.67%-3.87%-1.29%5.86%15.05%-34.24%-2.83%-36.04%
201710.87%12.50%-16.30%-10.46%-3.49%1.81%26.63%-2.80%7.69%-7.14%5.86%-0.99%
2016-20.77%6.80%-7.27%-4.90%-1.97%-15.87%-2.69%13.10%30.61%-10.43%-1.94%-8.91%
201511.11%29.44%-9.44%-11.37%5.88%34.34%-40.60%-3.16%-0.00%-12.09%-1.12%-2.26%
20143.91%3.08%-25.91%-9.42%2.97%0.00%-13.94%-6.70%-7.78%-9.43%-7.52%25.59%
201387.35%-22.78%-54.10%8.33%-9.89%-1.22%12.35%3.85%15.87%14.61%5.98%5.64%
201225.55%-20.60%-9.18%-6.62%-13.43%5.17%10.66%-16.30%16.37%20.15%-12.66%-8.33%
2011-6.26%-23.86%-27.57%45.67%-26.95%3.07%

BLRXSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current BioLineRx Ltd. Sharpe ratio is -0.69. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00MarchAprilMayJuneJulyAugust
-0.69
-0.31
BLRX (BioLineRx Ltd.)
Benchmark (^GSPC)

BLRXDividend History


BioLineRx Ltd. doesn't pay dividends

BLRXDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-97.92%
-13.58%
BLRX (BioLineRx Ltd.)
Benchmark (^GSPC)

BLRXWorst Drawdowns

The table below shows the maximum drawdowns of the BioLineRx Ltd.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the BioLineRx Ltd. is 98.74%, recorded on May 11, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.74%Jul 26, 20112665May 11, 2022

BLRXVolatility Chart

Current BioLineRx Ltd. volatility is 68.70%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%MarchAprilMayJuneJulyAugust
68.70%
19.67%
BLRX (BioLineRx Ltd.)
Benchmark (^GSPC)